Clinically important variants of diffuse large B-cell lymphoma

James O. Armitage

doi:10.1016/j.transci.2013.05.021

Clinically important variants of diffuse large B-cell lymphoma

James O. Armitage

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.

Original language	English (US)
Pages (from-to)	27-30
Number of pages	4
Journal	Transfusion and Apheresis Science
Volume	49
Issue number	1
DOIs	https://doi.org/10.1016/j.transci.2013.05.021
State	Published - Aug 2013

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/j.transci.2013.05.021

Cite this

@article{48bc81f2b6464fbaaa515bbda5ae8ff3,

title = "Clinically important variants of diffuse large B-cell lymphoma",

abstract = "It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.",

author = "Armitage, {James O.}",

year = "2013",

month = aug,

doi = "10.1016/j.transci.2013.05.021",

language = "English (US)",

volume = "49",

pages = "27--30",

journal = "Transfusion and Apheresis Science",

issn = "1473-0502",

publisher = "Elsevier Ltd",

number = "1",

}

TY - JOUR

T1 - Clinically important variants of diffuse large B-cell lymphoma

AU - Armitage, James O.

PY - 2013/8

Y1 - 2013/8

N2 - It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.

AB - It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.

UR - http://www.scopus.com/inward/record.url?scp=84882848051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882848051&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2013.05.021

DO - 10.1016/j.transci.2013.05.021

M3 - Article

C2 - 23790759

AN - SCOPUS:84882848051

SN - 1473-0502

VL - 49

SP - 27

EP - 30

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

IS - 1

ER -

Clinically important variants of diffuse large B-cell lymphoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this